NRx Pharmaceuticals, Inc.
NRXP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25 | -$30 | -$40 | -$93 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $4 | $8 |
| Change in WC | $5 | $5 | $1 | -$5 |
| Other Non-Cash | $9 | $3 | -$4 | $52 |
| Operating Cash Flow | -$11 | -$22 | -$40 | -$38 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | -$0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$3 | $10 | -$1 |
| Stock Issued | $6 | $8 | $23 | $37 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $1 | $0 | $28 |
| Financing Cash Flow | $7 | $6 | $32 | $63 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3 | -$15 | -$8 | $26 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5 | $20 | $28 | $2 |
| End Cash | $1 | $5 | $20 | $28 |
| Free Cash Flow | -$11 | -$22 | -$40 | -$38 |